Emerging evidence now implicates PRMT1 as a critical driver of CLD progression, suggesting that PRMT1‐mediated protein methylation is a pivotal mechanism influencing the pathogenesis of chronic hepatic disorders (Figure 4). This evidence concerns the gene PRMT1 and congenital secretory chloride diarrhea 1.